1Arroyo V,Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [ J ]. Hepatology,1996,23:164 - 176.
2Jalan R, Hayes PC. Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure [J]. Gut,2000,46:527 - 533.
3Gulberg V, Moller S, Henriksen JH, et al. Increased renal production of c -type natriuretic peptid (CNP) in patients with cirrhosis and functional renal failure[J]. Gut,2000,47:852 - 857.
4Borroni G, Maggi A, Sangiovanni A, et al. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients[J]. Dig Liver Dis,2000,32:605 - 610.
5Oh M S，Nephron，1995年，70卷，143页
6陈灏珠.实用内科学[M](第11版)[M].北京：人民卫生出版社,2001.10.
7Decaux G.Difference is solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985[].Journal of Laboratory and Clinical Medicine.2001
8Gadano A,Moreau R,Pessione F,et al.Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis[].Journal of Hepatology.2000
9Gines P,Jimenez W.Aquaretic agent: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
10Gines P,Jimenez W.Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis[].Journal of Hepatology.1996
